A groundbreaking vaccine reduced the risk of death or recurrence of melanoma by almost half, an encouraging signal for a ...

ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic immunotherapy candidate, MVR-T3011, will be presented at the 2026 European ...

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.

The Department of Health has decided to take back £1.5m from the project, Belfast Trust officials have told a Stormont ...

The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...

Moderna released full data on its closely watched cancer vaccine developed with Merck.

This week, we learned that surgery removed the cancer entirely and he wouldn’t need further treatment. Not so long ago, a ...

Details from a closely guarded mRNA-based cancer vaccine study were shared on social media.

Ron Duguay, who starred for the Rangers and played nearly 1,000 games in the NHL from the late 1970s through the '80s, has ...

The results are an important advance for the treatment of melanoma, oncologists said, because patients lived significantly ...

A large study found that some fertility treatments may be linked to a modestly higher risk of childhood cancer.